Protocol No.: TSOG101

Study to Evaluate Perioperative Circulating Tumor DNA as a Prognostic Biomarker in Patients Undergoing Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer
Principal Investigator
Toker, Alper
Phase
NA
Age Group
Adult
Applicable Disease Site
Lung Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Laura Tasker, BS
Research Project Coordinator
Phone: +1 304-293-2730

View on ClinicalTrials.gov